tiprankstipranks
Trending News
More News >
Runway Growth Finance Corp (RWAY)
NASDAQ:RWAY
US Market

Runway Growth Finance Corp (RWAY) AI Stock Analysis

Compare
320 Followers

Top Page

RWAY

Runway Growth Finance Corp

(NASDAQ:RWAY)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
$7.00
▲(2.34% Upside)
Action:ReiteratedDate:03/14/26
The score is held back primarily by weak technicals (broad downtrend with bearish momentum) and reduced confidence in the most recent reported financial statement fields. Offsetting factors include generally solid multi-year fundamentals and a constructive earnings-call outlook tied to the SWK acquisition and balance-sheet optimization, alongside a very high dividend yield (though earnings-based valuation is unclear due to the reported P/E).
Positive Factors
Strong liquidity & financing flexibility
A large liquidity buffer and meaningful unused borrowing capacity give the firm durable funding optionality to originate, support portfolio companies, close the SWK acquisition and withstand redemptions or market stress. Long-term, this reduces refinancing risk and preserves the ability to target conservative leverage.
Conservative credit mix; very low nonaccruals
A portfolio concentrated in first‑lien, senior secured lending with negligible nonaccruals signals disciplined underwriting and loss protection. This structural credit strength supports stable cash yields and lowers long‑run expected credit losses, helping sustain dividends and capital preservation.
SWK acquisition adds scale, diversification and NII accretion
Acquiring a $235M portfolio increases scale and sector diversification (more healthcare/life sciences) while reducing average position size ~22%. Expected mid‑single digit NII accretion and modest ROE expansion can structurally improve dividend coverage and lower single‑name concentration risk.
Negative Factors
Yield compression and NII decline
Sustained lower portfolio yields directly compress the spread over funding costs and reduce sustainable net investment income. For a BDC that distributes most earnings, prolonged yield pressure and reduced fee/prepayment income weaken dividend coverage and limit durable earnings growth prospects.
Prepayment/repayment‑driven earnings volatility
High and variable prepayments reduce recurring interest and upfront fee income, creating material quarter‑to‑quarter cashflow swings. This structural volatility complicates forecasting, dividend planning and reinvestment pacing, increasing execution risk for yield maintenance over medium term.
Historical leverage and 2025 balance‑sheet data inconsistency
Meaningful past leverage amplifies balance‑sheet sensitivity to asset stress. The apparent 2025 debt reporting inconsistency undermines transparent assessment of covenant headroom, refinancing risk and true leverage, complicating medium‑term credit and liquidity modeling for investors and counterparties.

Runway Growth Finance Corp (RWAY) vs. SPDR S&P 500 ETF (SPY)

Runway Growth Finance Corp Business Overview & Revenue Model

Company DescriptionRunway Growth Finance Corp. is a business development company specializing investments in senior-secured loans to late stage and growth companies. It prefers to make investments in companies engaged in the technology, life sciences, healthcare and information services, business services and select consumer services and products sectors. It prefers to investments in companies engaged in electronic equipment and instruments, systems software, hardware, storage and peripherals and specialized consumer services, application software, healthcare technology, internet software and services, data processing and outsourced services, internet retail, human resources and employment services, biotechnology, healthcare equipment and education services. It invests in senior secured loans between $10 million and $75 million.
How the Company Makes MoneyRWAY makes money primarily from investment income generated by its lending activities and, to a lesser extent, from equity-linked upside and other fees. The main revenue streams are: (1) Interest income on debt investments: The bulk of earnings comes from contractual interest received on loans (generally senior secured), including cash-pay interest and, when applicable, paid-in-kind (PIK) interest that accrues to principal. Floating-rate structures and reference rates can affect portfolio yield and interest income. (2) Fee income related to originations and lending: The company may earn upfront origination/structuring fees, commitment or unused facility fees, amendment/consent fees, and prepayment or exit fees when borrowers refinance or repay early; if not specifically disclosed for a given period, the existence and magnitude of each fee type is portfolio- and contract-dependent. (3) Equity and warrant gains: In connection with some loans, RWAY may receive warrants or other equity-linked positions; it can realize income through gains on sales, IPOs/M&A outcomes, or mark-to-market valuation increases (which can also reverse if valuations decline). (4) Other investment income: This can include income from any non-loan investments held in the portfolio; if not separately reported, treat as part of overall investment income. RWAY’s net earnings available to shareholders are driven by the spread between portfolio yields and its cost of capital (including interest expense on its own borrowings) and operating expenses, plus any realized/unrealized gains or losses on investments. The company is externally managed, so a meaningful component of expenses is management and incentive fees paid to its adviser, which affects net income but is not itself a revenue source.

Runway Growth Finance Corp Earnings Call Summary

Earnings Call Date:Mar 12, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 12, 2026
Earnings Call Sentiment Positive
The call conveyed a generally constructive outlook centered on strategic actions that strengthen the company’s balance sheet and diversify the portfolio — particularly the pending SWK acquisition, strong liquidity, active originations, and improvements in operating efficiency. These positives were tempered by near-term earnings pressure from normalized prepayment income, lower quarter-over-quarter yield and NII declines, and timing-related softness tied to the SWK close and debt redemptions. Overall, management emphasized conservative underwriting, low nonaccruals, and concrete actions (debt issuance, note redemptions, and expected accretion from SWK) to stabilize and modestly enhance long-term earnings power.
Q4-2025 Updates
Positive Updates
Investment Income and NII Delivered
Generated total investment income of $30.0M and net investment income (NII) of $11.6M in the fourth quarter, delivering $0.32 of NII per share and maintaining a base dividend of $0.33 per share with approximately $0.65 per share of spillover income at year-end.
Active Origination and Portfolio Additions
Completed seven investments in Q4 totaling $42.9M across technology, health care, and select consumer sectors (including a $20M mobility deal, $10M consumer SPV, $20M commitment to Shield Therapeutics with $2M funded at close, and $10.9M of follow-ons to existing portfolio companies).
SWK Acquisition Expected to Drive Diversification and Accretion
Announced acquisition of SWK Holdings expected to close in early April; SWK bring ~13 loans (~$235M fair value), equity positions and royalties, and will increase health care and life sciences exposure. Management expects run-rate NII accretion in the mid-single digits, modest ROE expansion, improved dividend coverage, and reduced average position size to $23.5M (2.2% of portfolio) from $30.3M (3.1%), a ~22% reduction in average position size.
Strong Liquidity and Financing Flexibility
Available liquidity of $395.2M as of 12/31/2025 (including borrowing capacity of $377M) and launched an underwritten public offering of $103.25M unsecured notes due Feb 2031 at 7.25%, while redeeming higher-coupon near-term notes to extend the debt maturity ladder and lower cost of funds.
Conservative Credit Profile and Low Nonaccruals
Portfolio remains almost exclusively first-lien senior secured loans with only one loan on nonaccrual (Domingo Healthcare) with a cost basis of $4.8M and fair value of $2.4M (50% of cost), representing just 0.25% of the total investment portfolio at fair value.
Operating Efficiency and Loss Reduction
Total operating expenses decreased to $18.4M from $21.0M (-12.4%), and net realized losses on investments improved to $0.377M from $1.3M (approximately -71%), showing tighter expense control and fewer realized losses.
Stable NAV, Modest Asset Base Contraction
Net assets of $484.9M and NAV per share of $13.42 as of 12/31/2025, a modest NAV decline of ~1% from $13.55. Total investment portfolio fair value was $927.4M, down 2% from $946.0M year-over-year.
Pipeline Momentum and Sourcing Benefits from BC Partners
Management reported a stronger origination pipeline year-over-year, citing greater deal flow and enhanced sourcing from BC Partners and expected additive sourcing from SWK, with measured optimism for 2026 despite seasonal Q1 cadence.
Negative Updates
Decline in Investment Income and NII
Total investment income decreased from $36.7M to $30.0M (≈ -18%), and net investment income decreased from $15.7M to $11.6M (≈ -26%), driven in part by normalized lower prepayment fee income and sequencing of portfolio activity.
Yield Compression Quarter-over-Quarter
Dollar-weighted average annualized yield on the debt portfolio fell to 14.2% in 2025 from 16.8% quarter-over-quarter (-2.6 percentage points, ≈ -15.5%) and decreased modestly year-over-year from 14.7% (-0.5 percentage points, ≈ -3.4%), reflecting lower prepayment income and a changing yield mix.
Prepayment and Repayment-Driven Volatility
The quarter featured two full and one partial repayments totaling $60.6M (plus scheduled amortization of $2.2M). Elevated prepayments have pressured short-term earnings power and contributed to lower NII and portfolio fair value dynamics.
Near-Term Headwinds and Timing Impact from SWK Close Delay
Management expects some softness in Q1 2026 earnings due to a modest delay in the SWK transaction close and a one-time $0.02 per share headwind related to the full redemption of 8% notes and partial redemption of 7.5% notes due 2027.
Small Decline in Net Assets and NAV
Net assets decreased to $484.9M from $489.5M (≈ -0.9%) and NAV per share declined ~1% to $13.42, indicating modest net-asset pressure over the period.
Repurchase Program Paused
Unable to utilize the stock repurchase program during the quarter because of the pending acquisition and regulatory blackout windows; repurchases unlikely until May post-close, removing a potential source of immediate shareholder value restoration.
Sequential Increase in Portfolio Risk Rating (Small)
Weighted average portfolio risk rating increased slightly to 2.45 from 2.42 (+0.03), reflecting a small shift in credit mix that management is addressing through diversification and smaller position sizes.
Company Guidance
The company guided that the SWK Holdings acquisition is expected to close in early April (around April 6) and will add a portfolio of 13 loans with ~ $235M fair value (total portfolio yield ~14%, debt-only ~16%), driving post-close leverage to just under 1.2x (targeting a 1.2x–1.3x run rate, generally not above 1.35x) and reducing average position size to $23.5M (2.2% of the portfolio) from $30.3M (3.1%), with run‑rate net investment income (NII) accretion in the mid‑single digits and modest ROE expansion and improved dividend coverage; they warned of Q1 earnings softness due to the slight timing delay and a $0.02 one‑time headwind from redemption of 8% and partial 7.5% 2027 notes. Key recent metrics referenced: Q4 total investment income $30.0M and NII $11.6M ($0.32 per share) with a base dividend of $0.33 and ~ $0.65 spillover income for year‑end; 2025 dollar‑weighted loan yield 14.2% (down from 16.8% sequentially and 14.7% year‑over‑year); total investment portfolio fair value $927.4M (‑2%), NAV $13.42 (‑1%), net assets $484.9M; liquidity $395.2M with $377M borrowing capacity; unfunded commitments $145.5M ( $122.8M debt, $22.7M JV equity; $32.4M milestone‑eligible); one nonaccrual (cost $4.8M, FV $2.4M, 0.25% of portfolio); and capital actions including a $103.25M 2031 note offering at 7.25% and redemptions of 7.5%/8% 2027 notes.

Runway Growth Finance Corp Financial Statement Overview

Summary
Multi-year revenue growth and improved cash generation through 2022–2024 support fundamentals, but meaningful leverage in 2022–2024 and apparent inconsistencies/zeros in 2025 (annual) income statement and debt fields reduce confidence in the latest-period earnings and balance-sheet assessment.
Income Statement
62
Positive
Revenue growth has been strong over time, accelerating from 2022–2024 and remaining positive in 2025 (annual). Profitability was very high in 2020–2024 with strong net profit margins, though margins were volatile year-to-year. A key weakness is data quality/visibility in 2025 (annual): profit and margin fields are reported as zero despite higher revenue, which creates uncertainty around the current earnings run-rate.
Balance Sheet
54
Neutral
The company maintains a sizable equity base relative to assets, but leverage has been meaningful in recent years (debt higher than equity in 2024, and near equity in 2022–2023). Return on equity improved into 2024, supporting the credit model, but the 2025 (annual) debt figure is shown as zero, which appears inconsistent versus prior years and reduces confidence in assessing current leverage and balance-sheet risk.
Cash Flow
67
Positive
Cash generation improved materially after negative operating and free cash flow in 2020–2021, turning positive and scaling in 2022–2024. In 2025 (annual), operating and free cash flow surged sharply versus 2024, indicating strong cash realization. The main weakness is volatility (including earlier negative years and a sharp 2024 decline versus 2023), and some ratio fields appear inconsistent with the underlying profitability figures.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue140.16M124.22M94.52M55.14M54.00M
Gross Profit109.99M85.89M55.88M41.38M49.81M
EBITDA76.72M73.61M44.34M32.25M45.62M
Net Income34.05M73.61M44.34M32.25M45.62M
Balance Sheet
Total Assets960.11M1.09B1.08B1.14B738.35M
Cash, Cash Equivalents and Short-Term Investments18.18M5.75M2.97M5.76M4.70M
Total Debt449.92M552.33M510.08M548.96M79.49M
Total Liabilities475.14M576.49M532.08M565.71M132.15M
Stockholders Equity484.97M514.87M547.07M576.05M606.20M
Cash Flow
Free Cash Flow186.31M50.49M112.44M48.98M-61.25M
Operating Cash Flow186.31M50.49M112.44M48.98M-61.25M
Investing Cash Flow148.26M-22.93M0.00-453.82M-120.84M
Financing Cash Flow-170.37M-66.81M-115.23M360.91M51.06M

Runway Growth Finance Corp Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.84
Price Trends
50DMA
8.14
Negative
100DMA
8.48
Negative
200DMA
9.01
Negative
Market Momentum
MACD
-0.35
Positive
RSI
30.24
Neutral
STOCH
29.31
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RWAY, the sentiment is Negative. The current price of 6.84 is below the 20-day moving average (MA) of 7.37, below the 50-day MA of 8.14, and below the 200-day MA of 9.01, indicating a bearish trend. The MACD of -0.35 indicates Positive momentum. The RSI at 30.24 is Neutral, neither overbought nor oversold. The STOCH value of 29.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RWAY.

Runway Growth Finance Corp Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$170.22M28.480.54%10.37%10.48%-30.67%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
$196.95M5.4411.82%4.44%15.52%2.05%
64
Neutral
$198.03M10.056.66%-5.29%
62
Neutral
$295.16M8.6612.12%2.99%9.63%77.14%
56
Neutral
$247.16M9.626.89%15.96%6.38%41.48%
52
Neutral
$157.69M-43.40-102.53%-82.33%-3365.80%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RWAY
Runway Growth Finance Corp
6.84
-1.93
-22.02%
MFIN
Medallion Financial
8.37
-0.04
-0.53%
RM
Regional Management
31.41
0.46
1.49%
YRD
Yiren Digital
1.97
-4.55
-69.79%
LPRO
Open Lending
1.34
-1.96
-59.39%
OPRT
Oportun Financial
4.45
-1.72
-27.88%

Runway Growth Finance Corp Corporate Events

Dividends
Runway Growth Finance Declares First-Quarter 2026 Dividend
Positive
Feb 26, 2026

Runway Growth Finance Corp., a specialty finance company providing flexible capital to late- and growth-stage firms as an alternative to equity, operates as a business development company and is externally managed by Runway Growth Capital LLC, an affiliate of BC Partners Advisors L.P. Based in Menlo Park and led by industry veteran David Spreng, it targets venture-backed companies with non-dilutive growth financing solutions.

On February 25, 2026, Runway Growth Finance’s board declared a first-quarter 2026 cash dividend of $0.33 per share, payable on or about March 24, 2026, to stockholders of record as of March 10, 2026. The announcement underscores the company’s stated intention to distribute substantially all available earnings on a quarterly basis and highlights the ongoing availability of its opt-out dividend reinvestment plan, under which non-opting stockholders automatically reinvest dividends into additional common shares.

The most recent analyst rating on (RWAY) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Runway Growth Finance Corp stock, see the RWAY Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Runway Growth Finance Issues New Notes for Refinancing
Positive
Feb 3, 2026

On February 3, 2025, Runway Growth Finance Corp. entered into a third supplemental indenture with U.S. Bank Trust Company to support the issuance and sale of $103.25 million of 7.25% unsecured notes due 2031, which rank pari passu with its other unsecured debt and are subject to covenants tied to leverage limits and distribution restrictions under the Investment Company Act of 1940. The transaction, which closed on February 3, 2026, is part of a balance sheet refinancing in which the company plans to use the proceeds to repay outstanding indebtedness, including redeeming all $51.75 million of its 8.00% notes and $40.25 million of its 7.50% notes, with the partial and full redemptions of these higher-coupon notes expected to occur on March 5, 2026 at $25 per note plus accrued interest, potentially lowering the firm’s funding costs and optimizing its liability profile.

The most recent analyst rating on (RWAY) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Runway Growth Finance Corp stock, see the RWAY Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Runway Growth Finance Announces New 2031 Notes Offering
Positive
Jan 29, 2026

On January 27, 2026, Runway Growth Finance Corp. entered into an underwriting agreement with Runway Growth Capital LLC and Oppenheimer & Co. Inc., as representative of a group of underwriters, to issue and sell $100 million in aggregate principal amount of 7.25% notes due 2031, with closing expected on February 3, 2026, subject to customary conditions. The company also granted underwriters a 30-day option to purchase up to an additional $15 million of the notes to cover any overallotments, signaling an effort to raise additional long-term capital and potentially broaden its investor base through a registered offering under its existing shelf registration statement.

The most recent analyst rating on (RWAY) stock is a Buy with a $10.50 price target. To see the full list of analyst forecasts on Runway Growth Finance Corp stock, see the RWAY Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 14, 2026